1 2 9 3 a r t I C l e S Defective formation or function of synapses in the CNS during development results in disorders of learning and memory, including autism and intellectual disability [1] [2] [3] . X-linked intellectual disability (XLID) is a heterogeneous condition that is caused by single gene mutations on the X chromosome 1-3 . Over half of the genes that are found to be mutated in XLID encode synaptic proteins involved in actin cytoskeleton rearrangement, synaptic plasticity, synapse formation or neurotransmission, although the precise roles of most of these genes remain unknown 4 .
a r t I C l e S
Defective formation or function of synapses in the CNS during development results in disorders of learning and memory, including autism and intellectual disability [1] [2] [3] . X-linked intellectual disability (XLID) is a heterogeneous condition that is caused by single gene mutations on the X chromosome [1] [2] [3] . Over half of the genes that are found to be mutated in XLID encode synaptic proteins involved in actin cytoskeleton rearrangement, synaptic plasticity, synapse formation or neurotransmission, although the precise roles of most of these genes remain unknown 4 .
One of the genes responsible for XLID is OPHN1, which encodes a synaptic RhoGTPase-activating protein (oligophrenin-1) that, among other things, regulates dendritic spine shape in the brain [5] [6] [7] . OPHN1's involvement in XLID was established by the identification of XLIDassociated OPHN1 mutations (balanced translocation t (X; 12) or frameshift deletion) in individuals with XLID 8 . Subsequently OPHN1 mutations were identified in families with intellectual disabilities associated with cerebellar hypoplasia or epilepsy [9] [10] [11] .
The oligophrenin-1 protein comprises an amino-terminal BAR (Bin-Amphiphysin-Rvs) domain that binds curved membranes, a pleckstrin homology domain that is thought to confer membrane binding specificity through interaction with phosphoinositides, a central RhoGAP domain, and three carboxyl-terminal proline-rich sequences that are putative SH3-binding sites for endocytic adaptor proteins 7, 8, 12 . Oligophrenin-1 is broadly expressed in the brain and is enriched in the hippocampus, cortex and cerebellum. It is associated with F-actin in growth cones and dendritic spines, suggesting that it participates in synapse formation or function 5, 6 . Oligophrenin-1 is also associated with Homer 6 , an adaptor molecule that influences dendritic spine morphology and synaptic transmission through interaction with Shank and with glutamate receptors [13] [14] [15] . In hippocampal slices and neuronal cultures, inactivation of oligophrenin-1 function affects the maturation and reduces the density of dendritic spines 6, 7, 12 . The oligophrenin-1 knockout mouse has impaired spatial learning, altered social behavior, novelty-driven hyperactivity and enlarged cerebral ventricles 7 . Loss of oligophrenin-1 also reduces synaptic vesicle endocytosis in the presynaptic compartment 12, 16 and affects the internalization and stability of AMPA receptors post-synaptically 12, 16 .
We found that oligophrenin-1 interacts with Rev-erbα. Rev-erbα is a nuclear receptor that suppresses gene transcription and is involved in circadian clock regulation 17 . The heme group is a physiological ligand of Rev-erbα that enhances its thermal stability and results in the recruitment of the co-repressor N-Cor 18 . Rev-erbα knockout mice have several defects that occur during the postnatal development of the cerebellar cortex, with delayed proliferation and migration of granule cells from the external granule cell layer together with increased apoptosis of neurons in the internal granule cell layer 19 .
We found that oligophrenin-1 interacts with Rev-erbα to protect it from degradation, caused it to localize in dendrites and suppressed its repressor activity. In addition, our results indicate that a circadian oscillator is present in hippocampus that is modulated by Rev-erbα and requires oligophrenin-1 for normal oscillation.
RESULTS

Oligophrenin-1 interacts with Rev-erba
Using the C terminus of oligophrenin-1 as bait in a yeast two-hybrid system, we screened 1.5 × 10 6 clones of a human fetal brain cDNA 1 2 9 4 VOLUME 14 | NUMBER 10 | OCTOBER 2011 nature neurOSCIenCe a r t I C l e S library. Four interacting cDNAs were isolated (clones 11, 19, 23 and 40; Fig. 1a) , all of which encoded Rev-erbα (also known as NR1D1). We then used the two-hybrid system to assess the interactions of two fragments (amino acids 550-633 and 634-802) of the C terminus of oligophrenin-1 as bait, with a minimal Rev-erbα cDNA clone (which does not contain the DNA-binding domain) as prey (Fig. 1b) . Activation of all three reporter genes (HIS3, LacZ and URA3; Fig. 1b ) indicated that the proximal fragment had a greater affinity for Reverbα than the distal fragment, suggesting that the oligophrenin-1's interaction with Rev-erbα is complex and involves different regions of the C-terminal of oligophrenin-1.
To confirm the interaction between oligophrenin-1 and Rev-erbα, we examined their interaction when overexpressed in COS7 cells. Fulllength myc-tagged Rev-erbα was co-transfected either with wild-type hemagglutinin-tagged oligophrenin-1 (HA-oligophrenin-1) or with HA-oligophrenin-1∆C. Oligophrenin-1∆C has a deleted C-terminal end and mimics one of the forms present in intellectual disability 8 .
We then examined the localization of these proteins in transfected COS7 cells. When expressed alone, Rev-erbα localized to the nucleus, which was visualized by colocalization with DAPI (a nuclear marker; Fig. 1c ). When oligophrenin-1 was expressed alone, it was present in the cytoplasm in regions enriched in F-actin (subcortical actin and stress fibers) with no detectable localization in the nucleus (Fig. 1c) , as has been described previously 5 . On coexpression with oligophrenin-1, Rev-erbα was present in both the nucleus and cytoplasm (Fig. 1c) , where it colocalized with oligophrenin-1. Notably, the localization of Rev-erbα to the cytoplasm was dependent on its interaction with the oligophrenin-1 C terminus, as Rev-erbα remained in the nucleus when it was coexpressed with oligophrenin-1∆C, the mutant that lacked the C-terminal tail and was unable to bind Rev-erbα (Fig. 1c) . We also found that Rev-erbα co-immunoprecipitated with wild-type oligophrenin-1, but not with oligophrenin-1∆C (Fig. 1d) .
To examine the interaction between oligophrenin-1 and Reverbα in vivo, we performed GST pulldown experiments on rat brain Ectopic expression of HA-oligophrenin-1 together with myc-Rev-erbα revealed colocalization of both proteins in the cytoplasm. When Rev-erbα was expressed alone (visualized with DAPI staining, top right) and coexpressed with HA-oligophrenin-1∆C, it was confined to the nucleus (bottom). Scale bar represents 10 µm. (d) The interaction between oligophrenin-1 and Rev-erbα was confirmed by co-immunoprecipitation (ip) experiments in COS7 cells. HA-oligophrenin-1 co-immunoprecipitated with myc-Rev-erbα, whereas HA-oligophrenin-1∆C did not. (e) GST pulldown experiments. Diagram with the two fragments of the C-terminal tail of oligophrenin-1 used in the GST pulldown assay (top). Purified GST550-633 bound Rev-erbα more strongly than GST676-802 in lysates from rat brain and hippocampal neurons. (f) Co-immunoprecipitation of oligophrenin-1 and Rev-erbα in rat brain lysate.
a r t I C l e S extracts and cultured hippocampal neuron lysates. The first 83 (550-633) and last 126 amino acids of the oligophrenin-1 C terminus fused to GST (but not GST alone) pulled down Rev-erbα from rat brain and hippocampal neuron lysates (Fig. 1e) . As in the two-hybrid system (Fig. 1b) , the proximal part of the oligophrenin-1 C terminus (amino acids 550-633), containing two proline-rich regions, interacted more strongly with Rev-erbα than the distal part (Fig. 1e) . Co-immunoprecipitation experiments from rat brain lysate (Fig. 1f) also revealed an interaction between oligophrenin-1 and Rev-erbα. These findings establish that oligophrenin-1 binds Rev-erbα via its C terminus in neurons and COS7 cells, and causes Rev-erbα to localize to the cytoplasm of COS7 cells.
Oligophrenin-1 reduces Rev-erba repression of transcription
To assess the functional significance of the interaction between oligophrenin-1 and Rev-erbα, we investigated oligophrenin-1's effect on transcription repression by Rev-erbα using a reporter assay in heterologous cells (HEK 293T). Previous studies have shown that Rev-erbα's ability to repress transcription of its own gene is strongly dependent on Rev-erbα protein binding to its response element on that gene 20, 21 , and can be followed by monitoring the activity of a luciferase reporter gene under the control of the SV40 promoter coupled to the response element (pSV40-RE). In HEK cells, we overexpressed the reporter construct alone (pSV40-RE) and used other constructs to overexpress GFP (control), myc-tagged Rev-erbα, myc-Rev-erbα and HA-oligophrenin-1, or myc-Rev-erbα and HA-oligophrenin-1∆C. We found that myc-Rev-erbα overexpression caused a fourfold repression of reporter gene (luciferase) transcription in HEK cells compared with cells overexpressing pSV40-RE alone (Fig. 2a) . Neither HA-oligophrenin-1 alone (data not shown) nor GFP alone (Fig. 2a) had any effect on reporter gene repression. However, luciferase expression was significantly higher (1.5-fold; Student's t test, *P < 0.05) in cells expressing both myc-Rev-erbα and HAoligophrenin-1 (transfection with 600 ng of each construct) compared (Fig. 2a) . We also found that the repression activity of Rev-erbα increased significantly (decreasing luciferase activity) as the amount of myc-Rev-erbα that was used in the transfection process (150, 300 and 600 ng) was increased (constant quantity of HA-oligophrenin-1 plasmid; Supplementary  Fig. 1a ). Furthermore, in cells expressing myc-Rev-erbα and HAoligophrenin-1∆C, luciferase expression was reduced to levels similar to those of cells overexpressing myc-Rev-erbα alone (Fig. 2a) .
These data indicate that oligophrenin-1 reduces the repressor activity of Rev-erbα.
To investigate whether oligophrenin-1 reduces Rev-erbα repressor activity by causing Rev-erbα to localize outside of the nucleus, we measured luciferase activity and myc-Rev-erbα expression in the nucleus and cytoplasm of HEK cells coexpressing myc-Rev-erbα with different amounts (150, 300 and 600 ng) of the plasmid encoding HA-oligophrenin-1. We found that luciferase activity increased (repression activity of Rev-erbα decreased) with the amount of HA-oligophrenin-1 that we transfected (Supplementary Fig. 1b) . Subcellular fractionation showed that HA-oligophrenin-1 only accumulated in the cytoplasm (Fig. 2b) , whereas myc-Rev-erbα accumulation in cytoplasm increased with the amount of HAoligophrenin-1 used in the transfection procedure (ratios normalized to Tubb expression: 0.25 ± 0.005 with 150 ng versus 0.33 ± 0.005 with 300 ng, P ≤ 0.001; 0.25 ± 0.005 with 150 ng versus 0.39 ± 0.006 with 600 ng, P ≤ 0.0001; 0.33 ± 0.005 with 300 ng versus 0.39 ± 0.006 with 600 ng, P ≤ 0.01; Fig. 2b) . Furthermore, the ratio of Rev-erbα in cytoplasm to the total quantity present increased as luciferase activity increased ( Supplementary Fig. 1c) , indicating that the repression activity of Rev-erbα correlated with its nuclear localization.
We then investigated whether oligophrenin-1 influenced Rev-erbα stability. Glycogen synthase kinase 3β (GSK3β) phosphorylates Rev-erbα, causing it to stabilize 22 , whereas kinase inhibition by lithium or small interfering RNA (siRNA) leads to a near-complete loss of endogenous Rev-erbα protein 22 . We transfected HEK cells (that endogenously express GSK3β) with GFP (as a control of transfection efficiency) and mycRev-erbα, alone or in combination with the dominant-negative form of HA-tagged GSK3β (HA-GSK3βDN) 22 , or with oligophrenin-1, and also with both HA-GSK3βDN and oligophrenin-1. We assessed myc-Rev-erbα expression 48 h later (Fig. 2c,d) . Myc-Rev-erbα was destabilized in cells coexpressing HA-GSK3βDN compared with cells that did not express HA-GSK3βDN (0.02 ± 0.001 versus 2.5 ± 0.15, P ≤ 0.0001; Fig. 2d ). However, myc-Rev-erbα expression was higher in cells overexpressing both oligophrenin-1 and HA-GSK3βDN than in those overexpressing HA-GSK3βDN, but not oligophrenin-1 (3.2 ± 0.15 versus 0.02 ± 0.001, P ≤ 0.0001; Fig. 2c,d ). These findings indicate that, in heterologous cells, oligophrenin-1 stabilizes Rev-erbα in the absence of active endogenous GSK3β.
To investigate how oligophrenin-1 protects Rev-erbα from degradation, we incubated HEK cells overexpressing myc-Rev-erbα alone or with HA-oligophrenin-1 (600 ng of plasmid transfected) for 4 h at 37 °C, with or without the proteasome inhibitor MG132 (10 µM), and assessed the distribution of myc-Rev-erbα in nucleus and cytoplasm. In HEK cells that were not treated with MG132, mycRev-erbα accumulated in the nucleus, as determined by western blot (Fig. 2e) . In cells that also expressed HA-oligophrenin-1, myc-Reverbα was present in both the nucleus and cytoplasm (Fig. 2e) . The ratio of cytoplasmic to total (nucleus plus cytoplasm) myc-Rev-erbα was 0.16 ± 0.007 in cells expressing myc-Rev-erbα alone and 0.44 ± 0.006 in cells expressing both myc-Rev-erbα and HA-oligophrenin-1 (P ≤ 0.0001; Fig. 2e ). When proteasomes were blocked by MG132, the accumulation of myc-Rev-erbα in nucleus and cytoplasm was similar in cells expressing myc-Rev-erbα alone and in those that also expressed HA-oligophrenin-1 (Fig. 2e) ; the cytoplasmic to total ratios of myc-Rev-erbα were 0.578 ± 0.0022 and 0.560 ± 0.004, respectively (Fig. 2e) . These findings indicate that, in heterologous cells, oligophrenin-1 protects myc-Rev-erbα from proteasome degradation.
We next performed subcellular fractionation to assess Rev-erbα protein levels by western blot in the nuclear fraction and post-nuclear supernatant of hippocampus from wild-type and Ophn1 −/− mice 7 . In wild-type hippocampus, Rev-erbα was present in both the nuclear and supernatant fractions, whereas, in Ophn1 −/− hippocampus, Rev-erbα was only present in the nuclear fraction (at a similar level to wild type; Fig. 2f) , and the overall levels of Rev-erbα protein (nuclear and supernatant) were higher in wild-type than in Ophn1 −/− hippocampus (blot integrated pixel intensity: 1.62 ± 0.06 versus 0.95 ± 0.03, P ≤ 0.001; Fig. 2f) . Furthermore, the supernatant to nuclear fraction ratio of Rev-erbα was higher in wild-type than in Ophn1 −/− hippocampus (0.26 ± 0.01 versus 0.48 ± 0.01, P ≤ 0.001; Fig. 2f) .
These findings were confirmed by our immunofluorescence study of Rev-erbα localization, which revealed that, in wild-type neurons, Reverbα was prominent in nuclei and was also present in dendrites, whereas, in Ophn1 −/− neurons, Rev-erbα immunostaining was still clearly evident a r t I C l e S in nuclei, but was less evident in dendrites (Supplementary Fig. 2) .
As a control, we also examined the localization of the transcription factor Sp1 in Ophn1 −/− and wild-type mouse neurons ( Supplementary  Fig. 2) , and found no differences in Sp1 immunostaining between Ophn1 −/− and wild-type mice (Supplementary Fig. 2 ).
To determine whether oligophrenin-1's absence resulted in an increase in endogenous Rev-erbα degradation in dendrites, we incubated hippocampal neurons overexpressing Ophn1 siRNA or scrambled siRNA 6, 12 for 4 h at 37 °C, with or without (untreated) the proteasome blocker MG132 (10 µM), and assessed the distribution of endogenous Rev-erbα in soma and dendrites. In untreated neurons overexpressing scrambled siRNA, western blot revealed that Reverbα accumulated in the soma and dendrites, whereas, in neurons overexpressing Ophn1 siRNA, Rev-erbα was present only in the soma (Fig. 2g) . Rev-erbα levels were higher in untreated neurons overexpressing scrambled siRNA than in those overexpressing Ophn1 siRNA (integrated pixel intensity: 1.85 ± 0.016 versus 1.11 ± 0.028, P ≤ 0.0001; Fig. 2g ). When proteasomes were blockaded by MG132, Rev-erbα protein was present in both the soma and dendrites (Fig. 2g) and its expression levels were similar irrespective of whether scrambled siRNA or Ophn1 siRNA was overexpressed (Fig. 2g) . In addition, Rev-erbα protein levels were higher in MG132-treated than in untreated neurons. These findings indicate that, in hippocampal neurons, oligophrenin-1 stabilizes endogenous Rev-erbα in dendrites by protecting it from proteasome degradation.
Altered circadian oscillations in hippocampus of Ophn1 −/− mice Given that Rev-erbα is known to repress its own promoter, we assessed the consequences of oligophrenin-1 loss on Rev-erbα transcription 21 . We used reverse-transcription PCR (RT-PCR) to determine the expression of Rev-erbα mRNA at circadian times (CT) 18, 0, 6 and 12 h in dark/dark conditions, in the hippocampus, cortex and cerebellum of wild-type and Ophn1 −/− mice. In the hippocampus of both wild-type and Ophn1 −/− mice, Rev-erbα mRNA expression oscillated over 24 h. In wild-type mice, the observed peak was between CT3-9, whereas the observed peak was between CT9-15 in Ophn1 −/− mice (Fig. 3a) , indicating a shift in the oscillation of Rev-erbα expression in hippocampus of Ophn1 −/− mice (F 3,24 = 3.96, P < 0.02; Fig. 3a) . The differences between genotypes were most significant (P < 0.05) at CT12 (ratios normalized to Ppia expression: 0.81 ± 0.077 in Ophn1 −/− , 0.656 ± 0.035 in wild type) and CT18 (0.587 ± 0.032 in Ophn1 −/− , 0.438 ± 0.013 in wild type). In cortex, Rev-erbα mRNA oscillations over 24 h were similar between genotypes, with Rev-erbα mRNA levels being higher overall in Ophn1 −/− animals (F 1,23 = 9.81, P = 0.005; Fig. 3) . In cerebellum, Rev-erbα mRNA also oscillated over 24 h (Supplementary Fig. 3a) and expression levels were similar in wild-type and Ophn1 −/− mice. These findings are consistent with greater expression of Rev-erbα mRNA in the cortex and hippocampus of Ophn1 −/− mice and a modest shift in the oscillation of Rev-erbα mRNA in the hippocampus of Ophn1 −/− compared with wild-type mice.
We next assessed the expression of Rev-erbα protein in wild-type and Ophn1 −/− mice over 24 h in dark/dark conditions. Protein levels oscillated over 24 h in both wild-type and Ophn1 −/− hippocampus and were similar at CT0 and CT6, but were higher in wild-type than in Ophn1 −/− mice at CT12 and CT18 (ratios normalized to Tubb expression: 1.64 ± 0.018 versus 1.38 ± 0.014 at CT12, P < 0.05; 2.03 ± 0.004 versus 1.74 ± 0.007, CT18, P < 0.05; Fig. 3b) . In cortex, Rev-erbα protein expression also oscillated, with expression being similar at all circadian times in Ophn1 −/− and wild-type mice (Fig. 3e) . These findings indicate that a loss of oligophrenin-1 interaction increases Rev-erbα protein degradation in the hippocampus at times around CT12-18, suggesting that oligophrenin-1 regulates Rev-erbα stability during circadian rhythms.
The reduced expression of Rev-erbα protein at CT12 and CT18 probably explains the increased Rev-erbα mRNA at the same time points, as the protein is no longer present at sufficient levels to repress its own transcription. These in vivo findings confirm that oligophrenin-1 stabilizes Rev-erbα in hippocampus.
We next assessed the expression of Bmal1 mRNA at CT18, 0, 6 and 12 in hippocampus, cortex and cerebellum of Ophn1 −/− and wild-type mice. Bmal1 is a clock gene that is known to be a target of Rev-erbα repression 17 . Bmal1 transcript levels oscillated over 24 h in both Ophn1 −/− and wild-type hippocampus, but were significantly higher in Ophn1 −/− mice at CT18 than in wild-type mice (ratios normalized to Values are means ± s.e.m.; *P < 0.05, **P < 0.01, ***P < 0.001 (ANOVA, Tukey test).
a r t I C l e S
Ppia expression: 0.632 ± 0.024 versus 0.474 ± 0.016, P < 0.05; Fig. 3c ).
In cortex, the oscillation of Bmal1 mRNA expression over 24 h was similar to that in hippocampus. ANOVA showed that the oscillations of Bmal1 transcripts in Ophn1 −/− and wild-type mice differed (P = 0.037), but pair-wise Bonferroni tests were not significant (P = 0.057; Fig. 3f ). Bmal1 mRNA expression also oscillated in cerebellum similarly in both Ophn1 −/− and wild-type mice ( Supplementary  Fig. 3b ). These results suggest that oligophrenin-1 regulates Reverbα stability during its circadian oscillations to thereby affect the expression of the clock gene Bmal1 in specific brain areas, particularly the hippocampus.
Oligophrenin-1 causes Rev-erba to localize to dendrites
To investigate the molecular basis of oligophrenin-1's ability to regulate the transcriptional activity of Rev-erbα, we manipulated oligophrenin-1 and Rev-erbα expression in cultured neurons. First, we investigated the localization of GFP-and myc-tagged Rev-erbα overexpressed in cultured hippocampal neurons, in combination with HA-oligophrenin-1, and in combination with HA-oligophrenin-1∆C. We found that exogenous Rev-erbα protein expression, as revealed by myc immunostaining, appeared concentrated in the nucleus but was also clearly present in dendrites (Fig. 4a) . When oligophrenin-1 was co-expressed, Rev-erbα still accumulated in the nucleus but also colocalized with oligophrenin-1 in dendrites and dendritic spines. The staining intensity of myc-Rev-erbα in dendrites was greater with oligophrenin-1 than with GFP control (98.76 ± 15.96 versus 12.19 ± 2.86, P < 0.001; Fig. 4) . Rev-erbα in dendrites was markedly reduced when oligophrenin-1∆C was coexpressed with Reverbα (5.48 ± 2.18 versus 12.19 ± 2.86, P = 0.046) and abolished with Ophn1 siRNA (0.51 ± 0.03 versus 12.19 ± 2.86, P = 0.005) (Fig. 4) . These findings indicate that oligophrenin-1 and Rev-erbα associate in hippocampal neurons where they colocalize in dendrites and spines (as also shown in Supplementary Fig. 2 ).
Synaptic activity induces Rev-erba localization to dendrites Synaptic activity induces a variety of changes in neurons, ranging from transient post-translational modifications to modulation of gene expression programs 23 . The signals generated in synapses must therefore be transported to the nucleus, and it has been shown in the sensory neurons of mollusk Aplysia and hippocampal neurons of mice that the classical nuclear import pathway is important for transporting synaptically generated signals into the nucleus during learning-related forms of plasticity 24 . Furthermore, a recent study found that synaptic activity induced by NMDA activation drives oligophrenin-1 into dendritic spines 12 . We therefore investigated whether increasing excitatory synaptic activity by blocking inhibitory GABAergic transmission using the GABA receptor antagonist bicuculline and blocking synaptic activity with the Na + channel blocker tetrodotoxin (TTX) has reciprocal effects on the localization of exogenous and endogenous Rev-erbα in the neuron. Hippocampal neurons were transfected with GFP and myc-Rev-erbα at 11 d in vitro (DIV), and treated with either 2 µM TTX or 40 µM bicuculline for 1.5 h at 20 DIV. Bicuculline resulted in major localization of myc-Rev-erbα to dendrites, whereas TTX reduced myc-Rev-erbα localization to dendrites (fluorescence of endogenous synaptic proteins, measured as average pixel intensity: bicuculline, 115.18 ± 18.29 versus untreated 12.19 ± 2.86, P < 0.001; TTX, 0.56 ± 0.09 versus untreated 12.19 ± 2.86, P < 0.01; Fig. 5a,b) .
These findings indicate that Rev-erbα localization is modified by changes in synaptic activity (as induced by bicuculline and TTX). As a control, we also tested whether synaptic activity influenced the localization of the overexpressed transcription factor HA-Sp1. Myc-Rev-erbα Merge TTX ** *** ** *** Figure 5 Synaptic activity induces localization of Rev-erbα at synapses. (a) AMPA receptor and oligophrenin-1 mediated Rev-erbα localization in dendrites and dendritic spines. Hippocampal neurons were transfected with GFP and myc-Rev-erbα at 11 DIV and were treated for 1.5 h with the indicated drugs at 20 DIV. Bicuculline (40 µM), but not TTX (2 µM), induced localization of myc-Rev-erbα in dendrites and spines. Dendritic localization of myc-Rev-erbα in bicuculline-treated neurons was prevented by addition of NBQX (100 µM), but not by the addition of AP5 (100 µM). Application of bicuculline to neurons transfected with Ophn1 siRNA did not result in localization of myc-Rev-erbα to dendrites or spines. Scale bar represents 10 µm. (b) Histograms show the intensity of myc-Rev-erbα staining in dendrites and spines in neurons transfected as in a. Bicuculline, but not TTX, resulted in major localization of myc-Rev-erbα to dendrites that was prevented by the addition of NBQX, but not AP5. Ophn1 siRNA abolished Rev-erbα localization to dendrites even in the presence of bicuculline. A.u., arbitrary units (average pixel intensity). Values are means ± s.e.m. **P < 0.01, ***P < 0.001 (ANOVA, Tukey test). a r t I C l e S Neither bicuculline nor TTX had any effect on HA-Sp1 localization in hippocampal neurons (Supplementary Fig. 4a) .
In additional experiments, we tested whether glutamate receptors were required for Rev-erbα localization to dendrites and spines. Dendritic localization of Rev-erbα in bicuculline-treated neurons was prevented by addition of the AMPA receptor antagonist 6-nitro-7-sulfamoylbenzoquinpxaline (NBQX, 100 µM; 10.65 ± 2.5 versus 115.18 ± 18.29, P < 0.001; Fig. 5a,b) , but not by addition of the NMDA receptor inhibitor (2R)-amino-5-phosphonopentanoate (AP5, 100 µM; 106.8 ± 11.55 versus 115.18 ± 18.29, P = 0.3; Fig. 5a,b) , indicating that AMPA receptor activation is required for the localization of Rev-erbα to dendrites. Application of bicuculline to neurons overexpressing Ophn1 siRNA did not induce Rev-erbα localization to dendrites.
We next examined the effects of oligophrenin-1 overexpression and chemically induced changes in synaptic activity on endogenous Rev-erbα localization. We found that bicuculline-treated, but not TTX-treated, neurons expressed more endogenous Rev-erbα in dendrites than did untreated cells (1.6-fold increase, P < 0.05). Neither bicuculline nor TTX had any effect on the localization of endogenous Sp1 in hippocampal neurons (Supplementary Fig. 4b ). We also found that cells overexpressing oligophrenin-1 expressed significantly more Reverbα in dendrites than cells that did not overexpress oligophrenin-1 (1.4-fold increase, P < 0.05; Fig. 6a,b) . In neurons transfected with Ophn1 siRNA and treated with bicuculline, we found a marked reduction (significant) in staining for Rev-erbα in dendrites compared with untreated neurons (2.9-fold decrease, P < 0.01; Fig. 6a,b) .
These results suggest that oligophrenin-1 is required for the synaptic activity-induced localization of Rev-erbα to dendritic spines. To corroborate this, we fractionated cell bodies (soma fraction) from pre-and postsynaptic components (dendrite fraction) in untreated and bicuculline-treated cultured rat hippocampal neurons 25 . As expected, bicuculline induced Rev-erbα accumulation in the dendrite fraction and reduced the quantity of protein in the soma (ratio of density in dendrite to soma: treated, 2.62 ± 0.09; untreated, 1.3 ± 0.09; P < 0.01; Fig. 6c) .
We then administered intraperitoneal kainate using a wild-type mouse model 26, 27 to stimulate neuronal discharge in the brain, and then examined the distribution of Rev-erbα in hippocampal slices. In untreated hippocampus, Rev-erbα was mainly present in the nucleus, whereas Rev-erbα appeared to be distributed throughout the neuropil after kainate stimulation and often colocalized with the synaptic marker PSD95 (Supplementary Fig. 5 ). Taken together, these results suggest that oligophrenin-1 regulates endogenous Rev-erbα localization to dendrites by controlling AMPA receptor stability at the synapse.
Oligophrenin-1 regulates endogenous Rev-erba transcription
We next examined the effect of chemically induced synaptic activity on the production of Rev-erbα transcripts in hippocampal neurons in the presence and absence of endogenous oligophrenin-1. First, we assessed Rev-erbα mRNA (RT-PCR) in cultured hippocampal neurons from wild-type and Ophn1 −/− mice. Rev-erbα mRNA levels were higher in Ophn1 −/− neurons (0.37 ± 0.01 in Ophn1 −/− versus 0.25 ± 0.005 in wild type, P < 0.05; Fig. 7a Values are means ± s.e.m. ## P < 0.01 (Student's t test). PSD95 is a synaptic marker; nuclear protein 4eBP1 was used as a soma marker. a r t I C l e S compared with untreated (0.48 ± 0.04 versus 0.25 ± 0.005, P < 0.01; Fig. 7a ). In Ophn1 −/− neurons, Rev-erbα mRNA expression was unchanged between treated than untreated neurons. Thus, bicucullineinduced synaptic activity increased Rev-erbα transcript expression in the presence of oligophrenin-1, but not in its absence (Fig. 7a) .
We next transfected hippocampal neurons with various types of Ophn1 siRNA and/or oligophrenin-1 constructs and treated them with bicuculline (40 µM, 24 h). In untreated neurons, Rev-erbα mRNA levels were higher when Ophn1 siRNA was overexpressed compared with scrambled siRNA (ratios normalized to Gapdh expression: 0.36 ± 0.004 versus 0.28 ± 0.007; P < 0.05; Fig. 7b) . Bicuculline treatment increased Rev-erbα mRNA levels in neurons overexpressing scrambled siRNA compared with untreated neurons (0.37 ± 0.007 versus 0.28 ± 0.007; P < 0.01), but had no effect on neurons in which oligophrenin-1 was knocked down (0.36 ± 0.004 untreated versus 0.31 ± 0.003 treated; Fig. 7b ). These findings indicate that, in hippocampal neurons, bicuculline-induced synaptic activity increases the transcription of Rev-erbα mRNA, but only in the presence of oligophrenin-1.
Finally, to gain insight into whether the interaction between oligophrenin-1 and Rev-erbα mediates Rev-erbα repressor activity, we investigated the effects of oligophrenin-1 overexpression and suppression on Rev-erbα transcripts. Hippocampal neurons were transfected with Ophn1 siRNA together with an Ophn1 variant resistant to this siRNA (siRNA rescue) or with Ophn1 siRNA together with a variant of Ophn1∆C resistant to siRNA (siRNA rescue ∆C). In untreated neurons overexpressing siRNA and the rescue construct, Rev-erbα mRNA levels were similar to those in untreated neurons overexpressing scrambled siRNA (0.29 ± 0.014 versus 0.28 ± 0.007; Fig. 7b ). Bicuculline application caused Rev-erbα mRNA to increase (compared with untreated) in neurons expressing Ophn1 siRNA and Ophn1 siRNA rescue (ratios normalized to Gapdh expression: 0.29 ± 0.014 untreated versus 0.39 ± 0.012 treated, P < 0.01), but not in neurons transfected with Ophn1 siRNA and Ophn1 siRNA rescue ∆C (Fig. 7b) . These results indicate that oligophrenin-1 increases synaptic activity-stimulated Rev-erbα transcription in neurons, which presumably has an important effect on Rev-erbα's suppressor activity.
DISCUSSION
Our results describe an interaction between the synaptic protein oligophrenin-1 and the transcription repressor Rev-erbα. We found that oligophrenin-1 reduced the repressor activity of Rev-erbα by causing it to localize outside of the nucleus and protecting it from degradation induced by GSK3β inactivation (which normally stabilizes Rev-erbα by phosphorylation). Furthermore, in the absence of oligophrenin-1, Rev-erbα levels decreased in the soma and its repressor activity was reduced.
We have also delineated a circadian oscillator in hippocampus, which is modulated, as expected, by Rev-erbα, but requires the presence of oligophrenin-1, as the rhythmic expression of Rev-erbα in dark-dark conditions was about 6 h later in Ophn1 −/− mice than in wild types. This same oscillator was present in cortex and cerebellum. In cortex, oligophrenin-1's absence had a significant effect (P = 0.005, ANOVA) on Rev-erbα oscillations, but its levels did not differ significantly (P = 0.061) at any time point. This finding suggests that oligophrenin-1's effect is not confined to the hippocampus, but occurs in other parts of the brain. In the cerebellum, Rev-erbα rhythms were unaffected by oligophrenin-1's absence in dark/dark conditions. The different results between brain regions may be related to the pattern of expression of Ophn1, which is enriched in hippocampus compared with cortex and cerebellum. The expression of the clock gene Bmal1, regulated by Rev-erbα 17 , was only weakly altered in the hippocampus of Ophn1 −/− mice.
How can the interaction between oligophrenin-1 and Rev-erbα be interpreted? The literature provides no indication that Rev-erbα has a functional role in dendrites and spines, although such a role cannot be excluded a priori. For example, it has been shown that Rev-erbα's nuclear repressor activity depends on the oxidation state of its heme moiety and the ability of nitric oxide (NO) to bind heme in reducing conditions. As NO is a neurotransmitter involved in long-term potentiation 28 , we speculate that a similar mechanism might occur in synapses: by binding to Rev-erbα heme, NO might regulate the transcriptional repressor activity of Rev-erbα in target neurons to influence the expression of protein complexes in the dendritic spines and long-term synaptic plasticity.
Oligophrenin-1's previously unsuspected role in circadian rhythms is equally intriguing. Our data suggest that the repression activity of Rev-erbα is regulated in a cyclic fashion by its degradation and that oligophrenin-1, together with GSK3β, controls its localization and stability. In humans, Rev-erbα's repressor activity is known to have circadian variation 29 . Oligophrenin-1 would serve to stabilize Reverbα in the cytoplasm, protecting it from degradation; only a minor fraction of Rev-erbα appears to be transported with oligophrenin-1 to dendritic spines. In Ophn1 −/− mice, we observed increased degradation of Rev-erbα and slower buildup in the nucleus, leading to higher Rev-erbα transcript levels in the later stages of the 24 h cycle (Fig. 3a) , as Rev-erbα protein represses Rev-erbα transcription 21 . The functional consequences of oligophrenin-1 loss on the Bmal1 clock remain to be explored. It is thought that Rev-erbα oscillations act as an additional stabilizing loop, helping to maintain the precision of circadian rhythms 17 .
Our finding that bicuculline-induced synaptic activity increased Rev-erbα transcript levels, but only in the presence of oligophrenin-1, reinforces the idea that oligophrenin-1 is involved in the control of circadian rhythms in the hippocampus. It was initially believed that only the suprachiasmatic nucleus was involved in generating circadian rhythms. However, in mammals, genes are expressed in circadian rhythms in the hippocampus [30] [31] [32] , olfactory bulb 33 , cerebellum 34 and other regions 35 . Increased synaptic activity can be a marker of the initiation of activity in the sleep-wake cycle of animals, and our data suggest that the oligophrenin-1-dependent increase in Rev-erbα transcription as a result of synaptic activity may be a means of entraining hippocampal circadian oscillations to activity signals from other parts of the brain. In Drosophila, levels of key synaptic proteins, such as α-DLG, synapsin and syntaxin, have been related to behavioral states correlated with the sleep-wake cycle 36 .
Rev-erbα transcription is rhythmic because it is enhanced by Bmal1 and is repressed by both Per-Cry 37,38 and the Rev-erbα protein 21 . Rev-erbα also represses Bmal1 transcription 17 .
We also found that that synaptic activity in vivo (wild-type mice) increased the localization of Rev-erbα protein to the cytoplasm and dendrites. Our results indicate that synaptic activity-induced Reverbα localization to dendrites is mediated by AMPA receptors. Again, this may not be functionally important, but could be an epiphenomenon arising from an interaction between 'synaptic' oligophrenin-1 and 'nuclear' Rev-erbα. It is known that the oligophrenin-1 localization to dentritic spines is driven by synaptic activity, where it complexes with, stabilizes and selectively activates AMPA receptors 39 .
In conclusion, our data reveal some interactions between synaptic activity and circadian oscillators and implicate oligophrenin-1 in its regulation, delineating a new means of communication between synapse and nucleus 24, 36, 40 . These findings are a further indication 36, 41 a r t I C l e S that cognitive ability is influenced by circadian rhythms and promise to provide insight into normal plasticity and the etiology of intellectual disability. Although the effect of oligophrenin-1 loss on circadian synaptic activity was modest, we speculate that it may have more profound effects during development and may be a major factor leading to mental compromise in persons with OPHN1 mutations.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
ONLINE METhODS
Yeast two-hybrid screening and cdnA constructs. For two-hybrid experiments, a fragment corresponding to the C terminus of oligophrenin-1 (amino acids 550-802) was cloned into the pDBLeu vector, in frame with the GAL4-binding domain, and used as bait to screen a human fetal brain cDNA library (ProQuest Pre-made cDNA Libraries) that had been cloned into the pPC86 vector. Positive colonies grew on plates containing 10 mM 3-AT without tryptophan, leucine or histamine and expressed all three reporter genes: HIS3, LacZ and URA3. cDNA plasmids from positive clones were recovered via DH5α E. coli, plated on Amp and sequenced.
For further two-hybrid experiments, two DNA fragments corresponding to the oligophrenin-1 C terminus (amino acids 550-633 and 634-802) were subcloned into pDBLeu and used as bait; the DNA fragment corresponding to amino acids 263-614 of Rev-erbα was subcloned into pPC86 plasmid and used as prey. Oligophrenin-1 with the hemagglutinin (HA) tag and Rev-erbα with the myc tag (tags inserted at N terminus) were each subcloned into the GW1-CMV expression vector (British Biotechnology). The truncated HA-oligophrenin-1∆C (amino acids 1-550) was made by PCR amplification with appropriate oligonucleotides and also subcloned into the GW1-CMV expression vector together with a HA-tag at the N terminus.
The GST-oligophrenin-1 fragments corresponding to amino acids 550-633 and 676-802 were cloned into the pGEX4T-3 vector. The Ophn1 siRNA target sequence was 5′-GAA CCT ATC TAC CAC TC-3′; the corresponding scrambled siRNA was 5′-GCT CAC CCT TCC TAC TCT C-3′ were cloned into lentiviral Pll 1.3 vector; both were described and characterized previously 12 . For rescue experiments, the constructs were made as described previously 12 .
Oligophrenin-1 was a gift from L. Van Aelst (Cold Spring Harbor Laboratory). GSK3βDN was a gift from J. Jaworski (International Institute of Molecular and Cell Biology); pGL2RE-SV40 was a gift from V. Laudet (Laboratoire de Biologie Moléculaire de la Cellule) 21 . luciferase assay. Luciferase was assayed using the Dual Luciferase Report Assay System (Promega) 42, 43 .
co-immunoprecipitation and gSt-pull down assays. Transfected COS7 cells were lysed with 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1% (wt/vol) NP40, 0.5% (wt/vol) deoxycholate, 0.05% (wt/vol) SDS and protease inhibitors (lysis buffer). Lysate samples (100 µg protein) were incubated overnight at 4 °C with rabbit antibody to HA and mouse antibody to myc (Santa Cruz Biotechnology), both at 5 µg ml −1 , in buffer A (200 mM NaCl, 10 mM EDTA, 10 mM Na2HPO4, 0.5% NP40, 0.1% SDS, 10 mM NaF, and Ser/Thr-and Tyr-phosphatase inhibitor cocktails).
Protein A agarose beads (Santa Cruz Biotechnology), washed in buffer A, were added and the incubation continued for 2 h. The beads were pelleted by centrifugation, washed five times with buffer A, resuspended in sample buffer for SDS-PAGE, and boiled for 5 min. The beads were again pelleted by centrifugation and the supernatants were run on a 7.5% SDS-PAGE gel. Protein bands were transferred to nitrocellulose membranes (Amersham) at 80 V for 120 min at 4 °C. Primary antibodies were applied overnight in blocking buffer (20 mM Tris (pH 7.4), 150 mM NaCl, 0.1% (wt/vol) Tween-20 and 3% (wt/vol) dried non-fat milk). Secondary antibodies (HRP-conjugated antibody to mouse or rabbit, Amersham) were used at a 1:2,000 dilution. The signal was detected using an ECL detection system. For GST pulldown experiments, hippocampal neuron lysates and rat brain extracts were incubated with 30 µg of GST fusion protein immobilized on GST 4B beads (GE Healthcare) for 3 h at 4 °C, washed five times in lysis buffer, and resuspended in 25 µl of SDS sample buffer. GST alone served as a control. Samples were separated by SDS-PAGE, followed by western blotting with appropriate antibodies. GST fusion proteins were prepared in BL21 E. coli and purified by standard procedures.
The following antibodies and dilutions were used: mouse antibody to HA (1:200, Roche Applied Science), rabbit antibody to Myc (1:200, Upstate Cell Signaling Solutions) and rabbit antibody to Rev-erbα (1:500, gift from V. Laudet, Laboratoire de Biologie Moléculaire de la Cellule).
